Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

20 HOURS AGO - Yahoo! News

A Must Read - Share

US approves injectable anti-cholesterol drug Repatha

US regulators on Thursday approved Repatha, the second injectable drug of its kind designed for certain patients with stubbornly high cholesterol which puts them at risk of heart disease. Repatha, also known as evolocumab, is made by Amgen and is part of a new class of drugs known as PCSK9 inhibitors, or antibodies which work on the liver to lower ...

Tags: US approves injectable anti-cholesterol drug Repatha,  Amgen Latest News

AUG 27, 2015 - New York Times

A Must Read - Share

F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class

The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.

Tags: F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class,  Amgen Latest News

AUG 27, 2015 - New York Times

A Must Read - Share

F.D.A. Approves a Second Drug for Cholesterol in a Potent New Class

The new drug, Repatha, is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.

Tags: F.D.A. Approves a Second Drug for Cholesterol in a Potent New Class,  Amgen Latest News

AUG 27, 2015 - Yahoo! News

A Must Read - Share

FDA approves Amgen's cholesterol-lowering drug Repatha

By Toni Clarke WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease. Last month the FDA approved a similar drug from Regeneron Pharmaceuticals Inc and Sanofi SA. The drugs belong to a potent new class of injectable LDL-lowering drugs known ...

Tags: FDA approves Amgen's cholesterol-lowering drug Repatha,  Amgen Latest News

AUG 27, 2015 - Yahoo! News

A Must Read - Share

Amgen wins approval for second biotech cholesterol drug

WASHINGTON (AP) — Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.

Tags: Amgen wins approval for second biotech cholesterol drug,  Amgen Latest News